429 related articles for article (PubMed ID: 29023400)
41. Nanospray technology for an in situ gelling nanoparticulate powder as a wound dressing.
De Cicco F; Porta A; Sansone F; Aquino RP; Del Gaudio P
Int J Pharm; 2014 Oct; 473(1-2):30-7. PubMed ID: 24979533
[TBL] [Abstract][Full Text] [Related]
42. Chitosan nanoparticle antigen uptake in epithelial monolayers can predict mucosal but not systemic in vivo immune response by oral delivery.
Cole H; Bryan D; Lancaster L; Mawas F; Vllasaliu D
Carbohydr Polym; 2018 Jun; 190():248-254. PubMed ID: 29628245
[TBL] [Abstract][Full Text] [Related]
43. Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide.
Di Martino A; Pavelkova A; Maciulyte S; Budriene S; Sedlarik V
Eur J Pharm Sci; 2016 Sep; 92():276-86. PubMed ID: 27154260
[TBL] [Abstract][Full Text] [Related]
44. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
[TBL] [Abstract][Full Text] [Related]
45. Fabrication and characterization of complex nanoparticles based on carboxymethyl short chain amylose and chitosan by ionic gelation.
Ji N; Hong Y; Gu Z; Cheng L; Li Z; Li C
Food Funct; 2018 May; 9(5):2902-2912. PubMed ID: 29725671
[TBL] [Abstract][Full Text] [Related]
46. Application of pH-Responsive Fucoidan/Chitosan Nanoparticles to Improve Oral Quercetin Delivery.
Barbosa AI; Costa Lima SA; Reis S
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669398
[TBL] [Abstract][Full Text] [Related]
47. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
Arif M; Raja MA; Zeenat S; Chi Z; Liu C
J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
[TBL] [Abstract][Full Text] [Related]
48. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
49. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.
Bhumkar DR; Joshi HM; Sastry M; Pokharkar VB
Pharm Res; 2007 Aug; 24(8):1415-26. PubMed ID: 17380266
[TBL] [Abstract][Full Text] [Related]
50. Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier.
Jung J; Arnold RD; Wicker L
Colloids Surf B Biointerfaces; 2013 Apr; 104():116-21. PubMed ID: 23298595
[TBL] [Abstract][Full Text] [Related]
51. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
Barakat NS; Almurshedi AS
J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
[TBL] [Abstract][Full Text] [Related]
52. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.
Luo Y; Wang Q
Int J Biol Macromol; 2014 Mar; 64():353-67. PubMed ID: 24360899
[TBL] [Abstract][Full Text] [Related]
53. Chitosan/pectin/gum Arabic polyelectrolyte complex: process-dependent appearance, microstructure analysis and its application.
Tsai RY; Chen PW; Kuo TY; Lin CM; Wang DM; Hsien TY; Hsieh HJ
Carbohydr Polym; 2014 Jan; 101():752-9. PubMed ID: 24299835
[TBL] [Abstract][Full Text] [Related]
54. Fabrication of a novel pH-sensitive glutaraldehyde cross-linked pectin nanogel for drug delivery.
Chang C; Wang ZC; Quan CY; Cheng H; Cheng SX; Zhang XZ; Zhuo RX
J Biomater Sci Polym Ed; 2007; 18(12):1591-9. PubMed ID: 17988522
[TBL] [Abstract][Full Text] [Related]
55. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
Gan Q; Wang T
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
[TBL] [Abstract][Full Text] [Related]
56. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
57. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis.
Elbaz NM; Khalil IA; Abd-Rabou AA; El-Sherbiny IM
Int J Biol Macromol; 2016 Nov; 92():254-269. PubMed ID: 27397719
[TBL] [Abstract][Full Text] [Related]
58. Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin.
Bigucci F; Luppi B; Cerchiara T; Sorrenti M; Bettinetti G; Rodriguez L; Zecchi V
Eur J Pharm Sci; 2008 Dec; 35(5):435-41. PubMed ID: 18951977
[TBL] [Abstract][Full Text] [Related]
59. Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.
Liu Y; Kong M; Feng C; Yang KK; Li Y; Su J; Cheng XJ; Park HJ; Chen XG
Colloids Surf B Biointerfaces; 2013 Mar; 103():345-53. PubMed ID: 23247264
[TBL] [Abstract][Full Text] [Related]
60. Pectin/Chitosan/Tripolyphosphate Nanoparticles: Efficient Carriers for Reducing Soil Sorption, Cytotoxicity, and Mutagenicity of Paraquat and Enhancing Its Herbicide Activity.
Rashidipour M; Maleki A; Kordi S; Birjandi M; Pajouhi N; Mohammadi E; Heydari R; Rezaee R; Rasoulian B; Davari B
J Agric Food Chem; 2019 May; 67(20):5736-5745. PubMed ID: 31042035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
